Cigna is kick-starting a new program that offers a $500 incentive for eligible members to switch to biosimilar drugs, the health insurer said this week.
Cigna is kick-starting a new program that offers a $500 incentive for eligible members to switch to biosimilar drugs, the health insurer said this week.